A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
RecruitingNCT05519475
Regeneron PharmaceuticalsMetabolic Dysfunction-Associated SteatoHepatitis (MASH)
Start: 2023-02-09End: 2028-12-07Target: 120Updated: 2026-07-08